HERlab

HERlab develops microbial production systems for animal therapeutics using synthetic biology.

Its platform applies AI-driven selection across more than a thousand yeast species to match therapeutic proteins with suitable production hosts. It also develops purification technology with veterinary manufacturing costs in mind.

The company's initial focus is antibody therapeutics for animal health, combining host selection and downstream processing to support practical protein production.